New incident report
Incident Report Number: 2021-1854
Registrant Reference Number: 2021-US-003022
Registrant Name (Full Legal Name no abbreviations): The Hartz Mountain Corporation
Address: 400 Plaza Drive
City: Secaucus
Prov / State: New Jersey
Country: USA
Postal Code: 07094-3688
Domestic Animal
Country: UNITED STATES
Prov / State: NEW YORK
Unknown
PMRA Registration No. PMRA Submission No. EPA Registration No. 2596-153
Product Name: Hartz UltraGuard Rid Flea and Tick Shampoo for Dogs 18oz
Liquid
Yes
Unknown
Site: Animal / Usage sur un animal domestique
Unknown
Animal's Owner
Dog / Chien
Neapolitan Mastiff
1
Male
2
80
lbs
Skin
Unknown / Inconnu
Unknown / Inconnu
System
Persisted until death
Unknown
Unknown
Died
Treatment / Traitement
(eg. description of the frequency and severity of the symptoms
On an unknown date in 2020, a 2 year old, 80 pound, male, Neapolitan Mastiff dog of unknown reproductive status, in unknown condition, with no known concomitant medical condition, was administered a unknown amount of Hartz UltraGuard Rid Flea and Tick Shampoo for Dogs 18oz (Phenothrin (Sumithrin)) via the topical route by the animal owner. The product was administered to the dog from two separate bottles with different lot numbers. On an unknown date post product administration, the dog died. No further information was provided or received.
Death
Assessment: This product contains a pyrethroid insecticide at low concentration and therefore has a wide margin of safety in dogs when used per label directions. Even if ingested, only minor GI upset would be expected. Very minimal information was provided in this case including the timeline of product use in relation to death. Without more information, this case cannot be evaluated further. The information contained in this report is based on self-reported statements provided to the registrant during telephone interview(s). These self-reported descriptions of an incident have not been independently verified to be factually correct or complete descriptions of the incident. For that reason, information contained in this report does not and cannot form the basis for a determination of whether the reported clinical effects are causally related to exposure to the product identified in the telephone interviews.